StonvexLoading…
StonvexStonvexStonvexCore line items from CLST's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $3.57M | $13.90M | $10.35M | $6.83M |
Operating Income | $684.00K | $2.50M | $1.95M | $1.35M |
Net Income | $558.00K | $2.05M | $1.60M | $1.11M |
EPS (Diluted) | $0.15 | $0.56 | $0.43 | $0.30 |
Total Assets | $288.51M | $282.93M | $283.83M | $273.79M |
Total Liabilities | $206.30M | $201.20M | $202.25M | $192.99M |
Cash & Equivalents | $38.53M | $25.20M | $37.27M | $40.06M |
Free Cash Flow OCF − CapEx | $657.00K | $3.10M | $2.31M | $1.48M |
Shares Outstanding | 4.06M | 4.07M | 4.13M | 4.14M |